ONCOSEC MEDICAL INC Chart calendar OncoSec Medical Inc
69d56cb.ZglyLeawYCnsWxELn4pO7GyHE8xCC57tSCLhLmrRYp4.VmtFa47JB0CkaVdz-e96gl_yW7wsPvaqP1u-fQ2DUOcVZSN-1fUJc6ARZg~0e5f6707bccf4cc22ea8fe522f0606ce
Past events on OncoSec Medical Inc
| 2023-05-14 | Shareholders Meeting |
| 2023-05-11 10:00 am | Sidoti Micro-Cap Virtual Conference |
| 2022-12-29 | Extraordinary Shareholders Meeting |
| 2022-12-06 01:40 pm | RHK Capital Disruptive Growth Conference |
| 2022-11-08 | Reverse Split: 1 of 22 |
| 2022-07-12 09:00 am | Annual General Meeting |
| 2022-06-13 | Q3 2022 Earnings Release |
| 2022-03-14 | Interim 2022 Earnings Release |
| 2021-12-06 | San Antonio Breast Cancer Symposium - Abstract No 2196 |
| 2021-11-12 07:00 am | Society for Immunotherapy of Cancer Meeting - Key Opinion Leaders |
| 2021-06-21 12:00 pm | Raymond James Human Health Innovations Conference |
| 2021-04-28 | Annual General Meeting |
| 2021-04-17 04:48 pm | Melanoma World Congress |
| 2021-04-17 04:28 pm | Melanoma World Congress |
| 2021-04-17 04:18 pm | Melanoma World Congress |
| 2021-04-17 04:15 pm | Melanoma World Congress |
| 2021-03-31 12:00 pm | LifeSci Advisors Investor Event - KOL Webinar on Anti-PD-1 Checkpoint Refractory Metastatic Melanoma |
| 2020-11-14 01:00 pm | Society of Immunotherapy of Cancer Meeting - Poster #: 480 |
| 2020-11-13 04:40 pm | Society of Immunotherapy of Cancer Meeting - Poster #: 799 |
| 2020-11-13 04:40 pm | Society of Immunotherapy of Cancer Meeting - Poster #789 |
Annual results
| Fiscal Period | July | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -36,1 -33,0 -9.56% | -30,4 -31,1 2.08% | -43,4 -44,6 2.66% | -48,4 -47,9 -1% | -37,0 -38,6 4.06% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -39,1 -36,0 -8.72% | -30,3 -31,3 3.19% | -43,1 -45,3 4.88% | -47,6 -46,8 -1.74% | -37,5 -39,0 3.81% |
|
Net income Million USD | Released Forecast Spread | -39,1 -36,1 -8.35% | -30,3 -30,9 1.96% | -42,3 -44,5 5.13% | -45,2 -46,8 3.43% | -34,2 -35,7 4.16% |
|
EPS USD | Released Forecast Spread | -216 -203 -6.14% | -94,4 -99,7 5.3% | -56,3 -65,1 13.51% | -30,1 -30,8 2.14% | -19,1 -19,8 3.33% |
| Announcement Date | 19/10/18 | 28/10/19 | 28/10/20 | 29/10/21 | 31/10/22 |
Quarterly results
| Fiscal Period | July | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -11,0 -13,4 17.72% | -10,4 -11,6 10.03% | -13,9 -13,4 -3.56% | -9,92 -16,4 39.35% | -9,42 -16,5 42.76% | -9,55 -10,8 11.6% | -8,13 -9,70 16.16% | -7,31 -8,80 16.97% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,7 -13,4 20.13% | -9,44 -12,2 22.3% | -14,2 -13,4 -6.07% | -9,81 -16,4 40.01% | -9,90 -16,5 39.79% | -9,58 -10,8 11.26% | -8,22 -9,70 15.3% | -8,06 -8,80 8.39% |
|
Net income Million USD | Released Forecast Spread | -10,7 -13,4 20.12% | -9,44 -11,6 18.37% | -11,8 -13,4 11.97% | -9,81 -16,4 40.01% | -9,91 -16,5 39.77% | -6,25 -10,8 42.15% | -8,22 -9,70 15.3% | -8,06 -8,80 8.39% |
|
EPS USD | Released Forecast Spread | -8,14 -8,95 9.02% | -5,50 -7,48 26.47% | -6,38 -7,48 14.71% | -5,50 -8,14 32.43% | -5,50 -9,24 40.48% | -3,52 -5,50 36% | -4,62 -5,28 12.5% | -4,50 -4,90 8.16% |
| Announcement Date | 15/03/21 | 11/06/21 | 29/10/21 | 15/12/21 | 15/03/22 | 14/06/22 | 31/10/22 | 15/12/22 |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-23 | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-23 | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-23 | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-24 | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| 2024-04-24 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Past sector events for OncoSec Medical Inc
| Today | SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-22 04:15 pm | MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
